PharmaDeals Research Reveals Early Signs of Recovery in Pharma Industry Deal Making

Oxford, UK, 22nd February 2011: PharmaDeals® research has revealed that the early stages of recovery are now evident within pharmaceutical deal making activity. The overall number of deals in 2010 grew relative to 2009, and whilst collaborative R&D deals continue to decline in numbers and value, licensing activity is on the increase.

As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals® Resource Expands its Deal Coverage

Oxford, UK, August 19 2010: PharmaVentures, the company behind the PharmaDeals®; range of business information, announced today the expansion of its PharmaDeals Agreements coverage that includes exclusive interviews with deal makers around the world. The announcement follows major enhancement of its dedicated, market leading platform delivering deal data and information to the pharmaceutical and biotechnology sector.

Biopharma Companies Gain Financially Through Unique Targeted Access to the Financial Community

OXFORD, UK, June 7, 2010 /PRNewswire: PharmaTelevision® today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector.

PharmaTelevision Partners with Reuters Insider to Deliver BioPharma Insight to the Global Financial Community

Oxford, UK, May 11, 2010: PharmaTelevision® announced that as of today the groundbreaking online TV channel for the BioPharma industry, is teaming up with Reuters Insider, a new interactive on-demand video platform designed to change the way financial professionals consume and distribute news, research and information.

Matrix Corporate Capital and PharmaVentures announce the signing of a Memorandum of Understanding (MOU)

London and Oxford, United Kingdom – March 15, 2010: Matrix Corporate Capital ('Matrix') and PharmaVentures Limited ('PharmaVentures') today announced the signing of a Memorandum of Understanding ('MOU') covering strategic transactions in the biotech, pharmaceutical and med tech sectors. The companies will work together to identify licensing, buyout, investment, IPO and consolidation opportunities which bring together both strategic expertise and capital from Europe's dedicated healthcare investors.

PTV Launches Broad Range of Services for the Global Biopharmaceutical Industry

PharmaTelevision Ltd announced today the launch of major new services to meet the growing demand for the production and dissemination of rich media content in the pharmaceutical and biotechnology sector. The company, a subsidiary of PharmaVentures, already provides the only online television channel dedicated to the bio-pharma industry, offering daily television news, analysis and feature interviews.

PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry

PharmaTelevision(R), the authoritative channel for the pharmaceutical, biotechnology and related industries, announced today the launch of its new service PharmaTelevision News (PTV News), the World's first daily television news and analysis programme for the sector.

PharmaTelevision Launches New Premium Content Service - Senior Executives at Pfizer, Johnson & Johnson, GlaxoSmithKline, and Other Big Pharma use New Media to Bring Fresh Exchange

PharmaTelevision, the authoritative channel for the pharmaceutical, biotechnology and related industries, announced today the launch of its new service, PharmaTelevision Premium Content. PTV Premium Content will include PTV News - a daily news and analysis service to be launched in August. Subscription to the service will be free until 30 September, 2009.

PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C.F.M. Group

PharmaVentures Ltd, announced today that it provided the Helsinn Group with the transaction advisory support for the successful sale of Helsinn Chemicals Ireland Ltd to the Medinco C.F.M. Group, which was announced on Monday.

Roche:Genentech Integration Latest: Exclusive Interview on PharmaTelevision

PharmaTelevision announced today that it is to broadcast an exclusive interview with Dan Zabrowski, Global Head, Pharma Partnering, Roche Pharmaceuticals Division and Joe McCracken, Vice President, Business Development, Genentech, on the Roche:Genentech integration, on June 4th 2009.

Pages

 

_

PharmaVentures InSights